In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users
Research output: Contribution to journal › Journal article › Research › peer-review
Both hallucinogens and 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") have direct agonistic effects on postsynaptic serotonin(2A) receptors, the key site for hallucinogenic actions. In addition, MDMA is a potent releaser and reuptake inhibitor of presynaptic serotonin.
| Original language | English |
|---|---|
| Journal | Archives of General Psychiatry |
| Volume | 68 |
| Issue number | 6 |
| Pages (from-to) | 562-76 |
| Number of pages | 15 |
| ISSN | 0003-990X |
| DOIs | |
| Publication status | Published - 2011 |
ID: 40165142